Streetbeat News

Equity Actions

COST

The analysis compares Costco Wholesale (COST) with its competitors in the Consumer Staples Distribution & Retail industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Costco's stock appears overvalued based on its high P/E, P/B, and P/S ratios compared to industry averages, but it shows strong profitability and market outperformance in terms of ROE and revenue growth. The company's lower EBITDA and gross profit relative to the industry suggest potential operational efficiency and cost management issues.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 3:00 pm

LOAR

Loar Holdings Inc (NYSE:LOAR) is set to IPO on April 25, with shares priced between $24.00 and $26.00. The company, specializing in aerospace and defense components, will have a 180-day insider lock-up period ending on October 22, 2024.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 3:00 pm

ISUN

iSun shares are trading lower following the announcement of a reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:54 pm

APH

CWS

MDCP

Amphenol Corporation (NYSE:APH) reported a 9% year-on-year sales increase for Q1 2024, reaching $3.256 billion and beating consensus estimates. Adjusted EPS was $0.80, surpassing the expected $0.73. The company announced a new $2 billion stock repurchase program and expects Q2 sales to increase by 6%-8%. APH stock has gained over 48% in the last 12 months. Investors can also gain exposure through VictoryShares THB Mid Cap ETF (NASDAQ:MDCP) and AdvisorShares Focused Equity ETF (NYSE:CWS).

Portfolio Pulse from Anusuya Lahiri

April 24, 2024 | 2:15 pm

GWW

W.W. Grainger, Inc. (NYSE:GWW) has increased its quarterly dividend by 10% to $2.05 per share and refreshed its share repurchase authorization to up to 5 million shares, replacing the existing authorization. The dividend is payable on June 1, 2024, to shareholders of record as of May 13, 2024. This marks the company's 53rd consecutive year of increased dividends, demonstrating its commitment to shareholder returns while continuing to invest in the business.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 2:08 pm

CYH

There was a notable options trading activity for Community Health Systems (CYH), involving a sweep of June 21 $4 call options. A total of 1,118 contracts were traded near the ask price at $0.399, compared to an open interest of 1,354 contracts. This activity occurred with CYH's stock reference price at $2.98.

Portfolio Pulse from Charles Gross

April 24, 2024 | 2:01 pm

TBLA

Analysts have mixed views on Taboola.com (NASDAQ:TBLA), with recent ratings showing a bullish trend. The average 12-month price target is $5.81, up 10.67% from the previous target. Taboola.com's financial performance is strong, with a revenue growth rate of 13.07%, a net margin of 0.89%, and an ROE of 0.35%. The company's debt-to-equity ratio is conservative at 0.2, indicating low dependency on debt financing.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 2:01 pm

IVZ

Invesco (NYSE:IVZ) has received neutral ratings from analysts, with a total of 6 indifferent ratings in the last three months. The average 12-month price target for Invesco is set at $17.25, with a recent decrease of 1.88% in the target. Analysts from firms including Goldman Sachs and Morgan Stanley have adjusted their price targets, reflecting a mix of lowered and raised expectations. Invesco's financial performance shows challenges with a revenue decline of -2.08% and below-average profitability metrics. The company's market capitalization is below industry averages, indicating potential growth and operational challenges.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 2:01 pm

GL

Analysts have provided diverse opinions on Globe Life (NYSE:GL), with recent evaluations showing a shift towards more cautious stances. The average 12-month price target has been adjusted to $116.8, down from $131.50, reflecting a decrease in optimism. Key financial indicators for Globe Life, such as market capitalization, revenue growth, net margin, ROE, and ROA, suggest a solid financial health, despite a lower growth rate compared to peers. The company's prudent debt management is also highlighted.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 2:00 pm

SNPX

Synaptogenix, Inc. (NASDAQ:SNPX) has regained compliance with Nasdaq's minimum bid price requirement for continued listing on The Nasdaq Capital Market. This follows a 1-for-25 reverse stock split conducted on April 4, 2024, aimed at increasing the stock's trading price above the $1.00 threshold. The company had previously been notified of non-compliance due to its stock price falling below $1.00 for 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 1:17 pm